Escholarshipmetadata only
Systematically optimized BCMA/CS1 bispecific CAR-T cells robustly control heterogeneous multiple myeloma
32 biomedical and clinical sciences (for-2020), 3211 oncology and carcinogenesis (for-2020), 3204 immunology (for-2020), rare diseases (rcdc), immunization (rcdc), genetics (rcdc), biotechnology (rcdc), hematology (rcdc)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 609399
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.